Biomarker in urine may offer noninvasive detection of prostate cancer

A research study has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection.

Leave a Reply

Your email address will not be published.